Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” from the six research firms that are currently covering the company, MarketBeat Ratings reports. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $19.00.
A number of research firms have issued reports on CCAP. Bank of America reduced their price target on Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating on the stock in a research report on Thursday, August 15th. Wells Fargo & Company decreased their price target on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 14th. Finally, LADENBURG THALM/SH SH initiated coverage on shares of Crescent Capital BDC in a research report on Monday, September 30th. They issued a “buy” rating and a $20.00 price objective on the stock.
Check Out Our Latest Report on Crescent Capital BDC
Crescent Capital BDC Stock Up 0.2 %
Crescent Capital BDC Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Tuesday, December 31st will be paid a $0.42 dividend. This is a positive change from Crescent Capital BDC’s previous quarterly dividend of $0.07. This represents a $1.68 annualized dividend and a yield of 8.84%. The ex-dividend date is Tuesday, December 31st. Crescent Capital BDC’s dividend payout ratio is currently 65.88%.
Institutional Inflows and Outflows
Several large investors have recently modified their holdings of the stock. Kovitz Investment Group Partners LLC acquired a new position in shares of Crescent Capital BDC during the 3rd quarter valued at $4,878,000. Stifel Financial Corp boosted its position in shares of Crescent Capital BDC by 53.1% in the third quarter. Stifel Financial Corp now owns 66,470 shares of the company’s stock worth $1,230,000 after buying an additional 23,055 shares during the period. HighTower Advisors LLC grew its stake in shares of Crescent Capital BDC by 0.5% in the third quarter. HighTower Advisors LLC now owns 141,838 shares of the company’s stock valued at $2,624,000 after buying an additional 768 shares in the last quarter. Confluence Investment Management LLC raised its holdings in shares of Crescent Capital BDC by 2.2% during the 3rd quarter. Confluence Investment Management LLC now owns 73,206 shares of the company’s stock valued at $1,354,000 after buying an additional 1,583 shares during the period. Finally, Van ECK Associates Corp lifted its position in Crescent Capital BDC by 68.0% during the 3rd quarter. Van ECK Associates Corp now owns 44,556 shares of the company’s stock worth $819,000 after acquiring an additional 18,035 shares in the last quarter. Institutional investors and hedge funds own 49.46% of the company’s stock.
Crescent Capital BDC Company Profile
Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Featured Articles
- Five stocks we like better than Crescent Capital BDC
- What Does Downgrade Mean in Investing?
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- Where to Find Earnings Call Transcripts
- Applied Materials Market Capitulates: Now is the Time to Buy
- When to Sell a Stock for Profit or Loss
- 3 Ultra-High Dividend Yield Stocks for the New Year
Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.